Showing 6311-6320 of 10618 results for "".
- AI’s Future and Current Role in Rheumatologyhttps://reachmd.com/news/ais-future-and-current-role-in-rheumatology/2467258/The rheumatologist of the future will see patients who have been assessed and triaged with artificial intelligence utilizing data from remote kiosk-placed ultrasound scanners and physician-directed algorithms. Practices will be broadly fueled by AI, which will screen charts, pr
- Ultrasound May Hold the Key to Future Treatments of Alzheimer's Diseasehttps://reachmd.com/news/ultrasound-may-hold-the-key-to-future-treatments-of-alzheimers-disease/2467228/MIAMI - Ultrasound is commonly used for prenatal care and screenings; however, the technology and its uses are evolving and could potentially be the future of treating Alzheimer's diseas
- Pediatric Surgical Opioid Prescribing Concentrated Among a Few Procedureshttps://reachmd.com/news/pediatric-surgical-opioid-prescribing-concentrated-among-a-few-procedures/2467197/by Elana Gotkine Pediatric surgical opioid prescribing is concentrated a
- ARMMS-T2D Study: Metabolic Surgery Outperforms Medical Interventions for Type 2 Diabeteshttps://reachmd.com/news/armms-t2d-study-metabolic-surgery-outperforms-medical-interventions-for-type-2-diabetes/2467153/The 12-year Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes, or ARMMS-T2D, clinical trial continues to provide significant findings on the benefits of bariatric surgery over medical manag
- Study Shows Effects of Year-Long Heavy Resistance Training on Vital Leg Strengthhttps://reachmd.com/news/study-shows-effects-of-year-long-heavy-resistance-training-on-vital-leg-strength/2467129/Twelve months of heavy resistance training-;exercise that makes muscles work against a force-;around retirement preserves vital leg strength years later, show the follow up results of a clinical trial, published online in the open access journal
- Sweat Health Monitor Measures Levels of Disease Markershttps://reachmd.com/news/sweat-health-monitor-measures-levels-of-disease-markers/2467131/PULLMAN, Wash. — A wearable health monitor developed by Washington State University researchers can reliably measure levels of important biochemicals in sweat during physical exercise. The 3D-printed monitor could someday provide a simple and non-invasive way to track he
- Olympian Suni Lee Speaks on AD Panelhttps://reachmd.com/news/olympian-suni-lee-speaks-ad-panel/2467107/Gymnast Suni Lee plans to defend her Olympic gold medal this summer in Paris, but first, she took time to participate in a panel discussion on a topic that has plagued her for several years: atopic dermatitis, or eczema. The 21-year-old American joined National Eczema Association President
- Evening Exercise Most Effective in Reducing Blood Sugar Levels for Overweight and Obese Adultshttps://reachmd.com/news/evening-exercise-most-effective-in-reducing-blood-sugar-levels-for-overweight-and-obese-adults/2467061/New research reveals that moderate to vigorous physical activity in the evening for sedentary adults with overweight and obesity is most beneficial in lowering daily blood sugar levels, according to a study published in Obesity, The Obesi
- Study Led by UChicago Medicine Physician Finds New Treatment for Ulcerative Colitishttps://reachmd.com/news/study-led-by-uchicago-medicine-physician-finds-new-treatment-for-ulcerative-colitis/2467079/A medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings of a global study led by University of Chicago Medicine’s
- Neoadjuvant Ipilimumab and Nivolumab Therapy Improves Survival in Stage III Melanomahttps://reachmd.com/news/neoadjuvant-ipilimumab-and-nivolumab-therapy-improves-survival-stage-iii-melanoma/2467064/New phase 3 study results from the NADINA study suggest that neoadjuvant (neoadj) therapy with ipilimumab (IPI) and nivolumab (NIVO) followed by response-driven adjuvant therapy was associated with increased event-free survival (EFS) in patients with macroscopic stage III melanoma. The re